The tweet was deleted by the author.
But we saved everything 🙂.
Emergent Biosolutions announced its commitment to developing, manufacturing, and delivering products aimed at protecting communities globally.
The company’s strategy is centered on scientific rigor and building partnerships, with a strong emphasis on quality and compliance. Emergent Biosolutions continues to prioritize innovation and public safety as core elements of its mission.
The company recently secured a $64.5 million contract modification to expand its supply of botulism antitoxin for U.S. health security. Emergent Biosolutions has also partnered with governments worldwide to strengthen health crisis response capabilities against pandemics and bioterrorism. These efforts align with its focus on public health preparedness.